MANSFIELD, Mass., Nov. 08, 2019 (GLOBE NEWSWIRE) — inTEST Corporation (NYSE American: INTT), a global supplier of precision-engineered solutions for use […]
CAMBRIDGE, Mass., Nov. 08, 2019 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is genetically […]
NEW YORK, Nov. 08, 2019 (GLOBE NEWSWIRE) — Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company, today released its […]